4Tsutsumi S, Ueta T, Shiba K, et al. Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center. Spine, 2006, 31 . 2992-2996.
6Leypold BG, Flanders AE, Schwartz ED, et al. The impact of methylprednisolone on lesion severity following spinal cord injury. Spine, 2007, 32:373-378.
7Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med, 1990, 322:1405-1411.
8Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg, 1991, 75:15.
9Tator CH. Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neuroehirurgie, 1991, 37:291.
10Tator CH, Koyanagi J. Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg, 1997, 86;483.
7Faisal T. Sayer,Erik Kronvall,Ola G. Nilsson.??Methylprednisolone treatment in acute spinal cord injury: the myth challenged through a structured analysis of published literature(J)The Spine Journal . 2006 (3)
